AK
Alyson Kelvin
University of Saskatchewan, Canada
Alyson Kelvin, PhD. Dr. Kelvin新しいタブ／ウィンドウで開く is a Scientist II at the Vaccine and Infectious Disease Organization (VIDO)新しいタブ／ウィンドウで開く, Saskatoon, Canada. She completed her HBSc at Western University (London, Canada, 2003) and her PhD at Queen’s University (Belfast, Northern Ireland, 2007). Dr. Kelvin’s expertise is in the fields of virology and vaccinology specifically focusing on the development of broadly protective vaccines for emerging viruses. She has researched several high-profile emerging viruses including the 2009 H1N1 pandemic influenza virus, avian H5N1 influenza virus, Mpox virus, SARS-CoV, and SARS-CoV-2. She is a member of expert panels for the control of emerging viruses including the Public Health Agency of Canada’s (PHAC) Avian Influenza Expert Panel. Dr. Kelvin has been recognized with a CEPI-CIHR Leadership Award in Vaccine Research as well as the Canadian Society for Virology Early Career Award of Excellence.